Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.002 Å; R factor = 0.043; wR factor = 0.120; data-to-parameter ratio = 22.9.
For the pharmacological activity of substituted 2-pyrazolines, see: Sahu et al. (2008) ; Farghaly et al. (1990) ; Adnan et al. (2005) ; Budakoti et al. (2008) ; Yar et al. (2007) ; Palaska et al. (1996) ; Jia et al. (2004) . For the experimental preparation, see: Bratenko et al. (2001) . For related structures, see: Fun et al. (2010 Fun et al. ( , 2011 . For reference bond lengths, see: Allen et al. (1987) .
Experimental
Crystal data C 30 H 24 N 4 M r = 440.53 Monoclinic, P2 1 =c a = 10.7841 (5) Å b = 11.0582 (6) Å c = 21.4820 (9) Å = 113.359 (2) V = 2351.82 (19) Å 3 Z = 4 Mo K radiation = 0.08 mm À1 T = 296 K 0.56 Â 0.54 Â 0.36 mm
Data collection
Bruker APEX DUO CCD areadetector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ) T min = 0.960, T max = 0.974 22465 measured reflections 7042 independent reflections 5057 reflections with I > 2(I) R int = 0.020 Refinement R[F 2 > 2(F 2 )] = 0.043 wR(F 2 ) = 0.120 S = 1.01 7042 reflections 307 parameters H-atom parameters constrained Á max = 0.19 e Å À3 Á min = À0.17 e Å À3 Table 1 Hydrogen-bond geometry (Å , ).
Cg1 is the centroid of the C1-C6 ring.
D-HÁ Á ÁA D -H HÁ Á ÁA D Á Á ÁA D -HÁ Á ÁA C8-H8AÁ Á ÁCg1 i 0.97 2.95 3.6999 (15) 135
Symmetry code: (i) Àx þ 1; Ày À 2; Àz.
Data collection: APEX2 (Bruker, 2009 ); cell refinement: SAINT (Bruker, 2009 ); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008) ; program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 
Comment
Pyrazolines are nitrogen-containing five-membered heterocyclic compounds and have received considerable attention in recent years due to their varied biological and pharmacological activities. Various substituted 2-pyrazolines have been associated with diverse pharmacological activities such as analgesic (Sahu et al., 2008) , anti-inflammatory (Farghaly et al., 1990) , anti-microbial (Adnan et al., 2005) , anti-amoebic (Budakoti et al., 2008) , anti-tubercular (Yar et al., 2007) , anti-depressant (Palaska et al., 1996) and anti-coagulant (Jia et al., 2004) properties. Based on the above biological activities exhibited by the pyrazolines, we have synthesized the title compound to study its crystal structure.
The molecular structure of the title compound, shown in Fig. 1 , contains two pyrazole (N1,N2/C10,C11,C24) and (N3,N4/ C7-C9) rings and four phenyl (C1-C6), (C12-C17), (C18-C23) and (C25-C30) rings. The pyrazole rings are essentially planar with maximum deviation of 0.003 (1) Å for atom C10 and 0.066 (1) Å for atom C9. The two pyrazole (N1,N2/ C10,C11,C24:N3,N4/C7-C9) rings make dihedral angles of 40.08 (6), 9.28 (6), 15.78 (8) and 17.25 (7)° with their attached phenyl (C12-C17/C18-C23):(C1-C6/C25-C30) rings respectively. The dihedral angle between the two pyrazole, (N1,N2/ C10,C11,C24: N3,N4/C7-C9), rings is 73.43 (6)°. Bond lengths (Allen et al., 1987) and angles are within normal ranges and are comparable to related structures (Fun et al., 2010; Fun et al., 2011) .
There are no significant intermolecular hydrogen bond interactions in the crystal structure. The structure is stabilized by C8-H8A···Cg1 (Table 1) interactions where Cg1 is the centroid of the C1-C6 ring.
Experimental
A mixture of (2E)-3-(1,3-diphenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-one (0.35 g, 1.0 mmol) and phenylhydrazine (0.162 g, 1.5 mmol) was refluxed in glacial acetic acid for 4 h. The mixture was then cooled to room temperature and the resulting solid was filtered and dried to get title compound. Yield: 0.22 g, 50%. M. p. 467-469 K (Bratenko et al., 2001) .
Refinement
All H atoms were positioned geometrically [C-H = 0.93-0.98 Å] and refined using a riding model with U iso (H) = 1.2 U eq (C). Fig. 1 . The molecular structure of the title compound with atom labels with 30% probability displacement ellipsoids.
Figures
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Hall symbol: -P 2ybc Cell parameters from 6778 reflections a = 10.7841 (5) Å θ = 2.9-30.3°b = 11.0582 (6) Å µ = 0.08 mm −1 c = 21.4820 (9) Å T = 296 K β = 113.359 (2) (11) 0.0567 (7) 0.0240 (9) 0.0331 (7) 0.0010 (7) 0.0614 (7) 0.0534 (7) 0.0468 (6) −0.0032 (6) 0.0198 (5) −0.0020 (5) C14 0.0897 (10) 0.0547 (8) 0.0492 (6) −0.0078 (7) 0.0187 (6) 0.0067 (6) C15 0.0713 (8) 0.0439 (7) 0.0641 (8) 0.0017 (6) 0.0036 (6) 0.0054 (6) C16 0.0517 (7) 0.0503 (7) 0.0751 (8) 0.0077 (6) 0.0171 (6) −0.0033 (6) C17 0.0425 (5) 0.0485 (6) 0.0598 (7) 0.0032 (5) 0.0197 (5) 0.0025 (5) C18 0.0463 (5) 0.0430 (6) 0.0411 (5) −0.0002 (5) 0.0191 (4) −0.0030 (4) C19 0.0487 (6) 0.0565 (8) 0.0801 (9) 0.0042 (6) 0.0281 (6) 0.0130 (7) C20 0.0558 (7) 0.0690 (9) 0.0812 (9) −0.0076 (7) 0.0334 (7) 0.0055 (7) C21 0.0755 (9) 0.0559 (8) 0.0617 (7) −0.0086 (7) 0.0350 (7) 0.0027 (6) C22 0.0761 (9) 0.0554 (8) 0.0710 (8) 0.0095 (7) 0.0349 (7) 0.0169 (7) C23 0.0534 (6) 0.0566 (7) 0.0602 (7) 0.0079 (6) 0.0247 (5) 0.0097 (6) C24 0.0367 (5) 0.0479 (6) 0.0493 (5) 0.0064 (4) 0.0168 (4) −0.0003 (5) C25 0.0448 (6) 0.0620 (8) 0.0486 (6) 0.0007 (5) 0.0182 (5) −0.0040 (5) C26 0.0602 (7) 0.0720 (9) 0.0511 (6) −0.0144 (6) 0.0255 (6) −0.0142 (6) C27 0.0547 (7) 0.0906 (11) 0.0434 (6) −0.0177 (7) 0.0093 (5) −0.0051 (6) C28 0.0436 (6) 0.0807 (10) 0.0535 (7) −0.0010 (6) 0.0062 (5) 0.0092 (7) C29 0.0395 (5) 0.0578 (7) 0.0522 (6) 0.0019 (5) 0.0141 (5) 0.0022 (5) supplementary materials sup-9 Fig. 1 
